Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis

Refractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without signal transducer and activator of transcription 1 gain-of-function mutations.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-05-29
DOI
https://doi.org/10.1093/cid/ciaf286
Citations
3
Primary Topic
Fungal Infections and Studies
Type
article
Field-Weighted Citation Impact
4.06

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis

Eva Le Run, Rajarshi Ghosh, Amy P. Hsu, Brenna LaBere et al.
3 citations
Clinical Infectious Diseases
Fungal Infections and Studies
4.06
article

Interferon-γ Therapy in Patients With Refractory Disseminated Coccidioidomycosis

Eva Le Run, Rajarshi Ghosh, Amy P. Hsu, Brenna LaBere, Atl Simon Arias Rivera, Lavenda Chirombo Kluczynski, Andrew J. Oler, Annalie J Harris, Scott Ostdiek, John K. De Witt, Nicolas Barros, James K. Woodward, L. Joseph Wheat, Chen Wang, Michell Lozano Chinga, Victoria Anderson, Steven M. Holland, Alexandra F. Freeman, Magdalena Walkiewicz, Wassim Ballan, Matthew W Smith, Morgan N. Similuk, Keith A. Sacco, Christa S. Zerbe, Fariba Donovan, Cindy Palmer, Lindsey B Rosen, Jennifer Daub, John N. Galgiani
article en
3 citations

Abstract

Refractory disseminated coccidioidomycosis (DCM) is a severe disease with limited treatment options. This report reviews our own and prior published experiences using adjunctive interferon-γ therapy in refractory DCM, showing overall favorable responses in patients without signal transducer and activator of transcription 1 gain-of-function mutations.

Clinical Infectious DiseasesVol. 81(6)
Indiana Department of Natural Resources (US), National Institutes of Health (US), University of Arizona (US), Barts Health NHS Trust (GB), Royal London Hospital (GB), Phoenix Children's Hospital (US), National Institute of Allergy and Infectious Diseases (US), BIO5 Institute, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research
Good health and well-being
Openalex Percentile: Top 6%
Fungal Infections and Studies
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.